Artificial intelligence is transforming medicine, but what does that mean for breast cancer screening? Researchers at UMass Chan Medical School are exploring how an AI-based tool might help identify ...

One way cancer specialists detect the disease is by examining cells and bodily fluids under a microscope, a time-consuming ...

The US Food and Drug Administration (FDA) has granted marketing clearance to Eyonis LCS, an artificial intelligence-powered software program to assist with lung cancer screening.

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced the launch of its enhanced Avantect(R) Pancreatic Cancer Test, which delivers ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. As part of its bid to transform the future of cancer screening and seize control of ...

Following eyonis® LCS' FDA 510 (k) clearance announced on February 9, 2026, Median has activated a phased U.S. launch strategy designed for disciplined national expansion. The Company has conducted ...

Cancer screening is at a turning point. For decades, most tests focused on one form of the disease — like mammograms for breast cancer or colonoscopies for colorectal cancer — but new advances have ...

SPRINGFIELD, Mo. (KY3) - Mercy is offering a new, revolutionary cancer screening that can detect around fifty types of cancer even earlier with a simple blood test. It’s called Multi-Cancer Early ...

The American College of Obstetricians and Gynecologists (ACOG) has updated its breast cancer screening guidelines, recommending that individuals at an average risk for breast cancer initiate ...

Colorectal cancer is the second-leading cause of cancer related death in the U.S., with nearly 53,000 1 fatalities expected in 2025. While the burden of this disease is significant, advancements in ...